Home Stock

Stock Research: Syngene International

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Syngene International

NSI:SYNGENE INE398R01022
8
  • Value
    20
  • Growth
    20
  • Safety
    Safety
    36
  • Combined
    6
  • Sentiment
    44
  • 360° View
    360° View
    8
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Syngene International Limited is an India-based integrated research, development, and manufacturing services company. It serves the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors with services including discovery, development, manufacturing, and integrated drug discovery platforms. In the last fiscal year, the company had a market cap of $3121 million, profits of $308 million, revenue of $426 million, and 6533 employees.

more

ANALYSIS: With an Obermatt 360° View of 8 (better than 8% compared with alternatives), overall professional sentiment and financial characteristics for the stock Syngene International are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Syngene International. The consolidated Value Rank has a low rank of 20 which means that the share price of Syngene International is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 80% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 20, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 20% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 36, which means that the company has a riskier financing structure than 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 44, which means that professional investors are more pessimistic about the stock than for 56% of alternative investment opportunities. ...read more

more
Strongest Rank Refinancing
Weakest Rank Capital Growth
Country India
Industry Life Sciences Tools & Services
Size Medium
Website syngeneintl.com
Index
Syngene International stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Jun-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 13 10 3
Growth
20 49 43 47
Safety
Safety
36 56 67 49
Sentiment
44 5 27 56
360° View
360° View
8 4 10 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
35 29 46 3
Opinions Change
50 15 50 30
Pro Holdings
n/a 16 35 100
Market Pulse
53 34 53 69
Sentiment
44 5 27 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 13 10 3
Growth
20 49 43 47
Safety Safety
36 56 67 49
Combined
6 14 23 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
30 25 22 9
Price vs. Earnings (P/E)
12 15 12 9
Price vs. Book (P/B)
40 28 28 19
Dividend Yield
33 14 15 17
Value
20 13 10 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
36 85 96 80
Profit Growth
20 12 46 38
Capital Growth
100 85 9 21
Stock Returns
11 37 49 49
Growth
20 49 43 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
67 62 58 50
Refinancing
6 27 39 35
Liquidity
48 57 64 56
Safety Safety
36 56 67 49

Similar Stocks

Discover high‑ranked alternatives to Syngene International and broaden your portfolio horizons.

AIA Engineering

NSI:AIAENG
Country: India
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Gujarat Gas

NSI:GUJGASLTD
Country: India
Industry: Gas Utilities
Size: Large
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Cipla

NSI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews